Metraipolis › archive › dc_ccbc90386f66

GSK3i combinatorial treatments affect CDK4/6 and compensatory pathways in 3D preclinical models of pancreatic neuroendocrine tumors — Europe PMC PMID:41873693

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41873693
DOI
10.1242/bio.062358
License (as archived)
solo-consultazione
Archived
2026-11-04T01:28:26.472Z
SHA-256 of the archived text
f435cc40d156aef7862750b93119c92272565846385295c46bb5f7663807d4ae
Stable URL of this page
https://metraipolis.com/documento/dc_ccbc90386f66

How to cite

GSK3i combinatorial treatments affect CDK4/6 and compensatory pathways in 3D preclinical models of pancreatic neuroendocrine tumors — Europe PMC PMID:41873693 — Europe PMC (en), https://europepmc.org/article/MED/41873693 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ccbc90386f66 (Metraipolis archive dc_ccbc90386f66, sha256 f435cc40d156aef7862750b93119c92272565846385295c46bb5f7663807d4ae)
BibTeX
@misc{dcccbc90386f66,
  title = {GSK3i combinatorial treatments affect CDK4/6 and compensatory pathways in 3D preclinical models of pancreatic neuroendocrine tumors — Europe PMC PMID:41873693},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41873693},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ccbc90386f66; sha256 f435cc40d156aef7862750b93119c92272565846385295c46bb5f7663807d4ae},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41873693. Agents can read the archived copy with the MCP tool read_document.